Cargando…

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers

Diabetes mellitus (DM) is a frequently encountered disease with important morbidity and mortality. The aim of this study is to document the importance of 1,5-anhydroglucitol (1,5-AG) for the diagnosis of prediabetes and DM, as well as to compare the 1,5-AG with other glycemic markers in order to und...

Descripción completa

Detalles Bibliográficos
Autores principales: Malkan, Umit Yavuz, Gunes, Gursel, Corakci, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628038/
https://www.ncbi.nlm.nih.gov/pubmed/26543722
http://dx.doi.org/10.1186/s40064-015-1389-5
_version_ 1782398370735718400
author Malkan, Umit Yavuz
Gunes, Gursel
Corakci, Ahmet
author_facet Malkan, Umit Yavuz
Gunes, Gursel
Corakci, Ahmet
author_sort Malkan, Umit Yavuz
collection PubMed
description Diabetes mellitus (DM) is a frequently encountered disease with important morbidity and mortality. The aim of this study is to document the importance of 1,5-anhydroglucitol (1,5-AG) for the diagnosis of prediabetes and DM, as well as to compare the 1,5-AG with other glycemic markers in order to understand which one is the better diagnostic tool. Between April 2012 and December 2012, 128 participants enrolled in the study. Participants were split into five groups that are IFG, IGT, IFG+IGT, diabetic and control groups by their OGTT results. The diagnostic value of markers was compared by ROC (receiver operating characteristic) method. The mean serum 1,5-AG levels in the diabetic group (33.38 nmol/ml) were lower than, IFG (59.83 nmol/ml), IGT (54.44 nmol/ml), IFG+IGT (51.98 nmol/ml) and control groups (73.24 nmol/ml). When analyzed in the total study population serum 1,5-AG levels did not differ by gender significantly. When analyzed in the total study population, 1,5-AG correlates inversely with age significantly (p = 0.036). In subgroup analysis, in the control group, serum 1,5-AG level was also inversely correlated with age (p = 0.087). The best marker for the diagnosis of prediabetes and DM was fasting plasma glucose (FPG). 1,5-AG was not found to be effective for the diagnosis of DM. This study, contributes to our knowledge of the efficiency and cut-off values of 1,5-AG for the diagnosis of prediabetes and DM. In future, there is a need for larger studies with more standardized and commonly used measurement methods for 1,5-AG, in order to evaluate the efficiency of 1,5-AG for the diagnosis of prediabetes and DM.
format Online
Article
Text
id pubmed-4628038
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-46280382015-11-05 Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers Malkan, Umit Yavuz Gunes, Gursel Corakci, Ahmet Springerplus Research Diabetes mellitus (DM) is a frequently encountered disease with important morbidity and mortality. The aim of this study is to document the importance of 1,5-anhydroglucitol (1,5-AG) for the diagnosis of prediabetes and DM, as well as to compare the 1,5-AG with other glycemic markers in order to understand which one is the better diagnostic tool. Between April 2012 and December 2012, 128 participants enrolled in the study. Participants were split into five groups that are IFG, IGT, IFG+IGT, diabetic and control groups by their OGTT results. The diagnostic value of markers was compared by ROC (receiver operating characteristic) method. The mean serum 1,5-AG levels in the diabetic group (33.38 nmol/ml) were lower than, IFG (59.83 nmol/ml), IGT (54.44 nmol/ml), IFG+IGT (51.98 nmol/ml) and control groups (73.24 nmol/ml). When analyzed in the total study population serum 1,5-AG levels did not differ by gender significantly. When analyzed in the total study population, 1,5-AG correlates inversely with age significantly (p = 0.036). In subgroup analysis, in the control group, serum 1,5-AG level was also inversely correlated with age (p = 0.087). The best marker for the diagnosis of prediabetes and DM was fasting plasma glucose (FPG). 1,5-AG was not found to be effective for the diagnosis of DM. This study, contributes to our knowledge of the efficiency and cut-off values of 1,5-AG for the diagnosis of prediabetes and DM. In future, there is a need for larger studies with more standardized and commonly used measurement methods for 1,5-AG, in order to evaluate the efficiency of 1,5-AG for the diagnosis of prediabetes and DM. Springer International Publishing 2015-10-09 /pmc/articles/PMC4628038/ /pubmed/26543722 http://dx.doi.org/10.1186/s40064-015-1389-5 Text en © Malkan et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Malkan, Umit Yavuz
Gunes, Gursel
Corakci, Ahmet
Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
title Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
title_full Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
title_fullStr Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
title_full_unstemmed Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
title_short Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
title_sort rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628038/
https://www.ncbi.nlm.nih.gov/pubmed/26543722
http://dx.doi.org/10.1186/s40064-015-1389-5
work_keys_str_mv AT malkanumityavuz rationaldiagnosesofdiabetesthecomparisonof15anhydroglucitolwithotherglycemicmarkers
AT gunesgursel rationaldiagnosesofdiabetesthecomparisonof15anhydroglucitolwithotherglycemicmarkers
AT corakciahmet rationaldiagnosesofdiabetesthecomparisonof15anhydroglucitolwithotherglycemicmarkers